MPLN partners with ArcherDX to offer ArcherĀ® NGS assays to global biopharma

Posted on July 19 2016 by J Seabrook

Boulder, COLORADO – ArcherDX, Inc., has announced that Molecular Pathology Laboratory Network, Inc. (MPLN) is now a Certified Service Provider of Archer® FusionPlex® NGS assays. MPLN will offer a custom sarcoma analysis service that…
Read more


MPLN’s LIS Blue is launching June 20

Posted on May 26 2016 by Jonathan Mulkey

MPLN LIS Blue v7 Ocean
Launch date: June 20, 2016

Our next-generation laboratory information system (LIS) has been redesigned from the ground…
Read more

MPLN expands Next Generation Sequencing offering with Solid Tumor Panels

Posted on September 28 2015 by J Seabrook

MARYVILLE, Tenn. – (Sept 17, 2015) – Molecular Pathology Laboratory Network (MPLN) today announced that it is expanding its integrated oncology specialty testing offering to include Next Generation Sequencing assays for solid tumor. The…
Read more

CMS Issues Clarifying Questions and Answers on ICD-10

Posted on September 23 2015 by J Seabrook

CMS Issues Clarifying Questions and Answers Related to the July 6, 2015 CMS/AMA Joint Announcement and Guidance Regarding ICD-10 Flexibilities.

In response to questions from the health care community, CMS has developed a Frequently Asked Questions…
Read more


Advancing Pathology and Cancer Research with NGS illumina Webinar Sep 23rd 2015

Posted on September 14 2015 by J Seabrook

Join Jamie Platt PhD, Vice President, Genomic Solutions, for a webinar on Advancing Pathology and Cancer research as she discusses the benefits of integrating NGS into clinical oncology research.

Dr. Platt will present an overview of the utility,…
Read more

1 2 3 4 5 6 7 8